ArticleBreast (Edinburgh, Scotland)2020

Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model.

Luisa Carbognin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.